Inotiv Inc reports results for the quarter ended December 31 - Earnings Summary

Inotiv

06/02/2025 02:36

* Inotiv Inc  NOTV.OQ  reported a quarterly adjusted loss of
$1.02​​ per share for the quarter ended December 31, lower than
the same quarter last year, when the company reported EPS of -60
cents.  The mean expectation of three analysts for the quarter
was for a loss of 95 cents per share. Wall Street expected
results to range from -98 cents to -92 cents per share.
    * Revenue fell 11.5% to $119.88 million from a year ago;
analysts
expected $121.83 million. 
    * Inotiv Inc's reported EPS for the quarter was a loss of
$1.02​.
    * The company reported a quarterly loss of $27.63 million.
    * Inotiv Inc shares had risen by 8.6% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 41.8%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Inotiv Inc is
$6.00 
This summary was machine generated from LSEG data February 6 at
02:35 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      -0.95          -1.02          Missed
 Sep. 30 2024      -0.91          -0.73          Beat
 Jun. 30 2024      -0.83          -1.00          Missed
 Mar. 31 2024      -0.54          -1.86          Missed